ETON
Eton Pharmaceuticals Inc
57.10$
+3.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +41.4% | -85.8% | +986.1% | |
| – | +384.6% | +609.5% | +45.6% | -29.0% | +284.0% | -49.2% | +27.2% | +252.9% | |
| – | -30.0% | +2.1% | +36.4% | +31.3% | +24.8% | -25.6% | +0.9% | +74.2% | |
| – | +64.0% | -57.4% | +103.4% | -26.2% | +48.8% | – | – | – | |
| – | -84.1% | -2,177.8% | – | -713.7% | – | -53.9% | -119.8% | – | |
| – | +81.5% | +682.2% | -97.3% | +6,418.0% | -14.5% | -72.2% | -96.6% | +1,180.8% | |
| – | +81.5% | +682.2% | -97.3% | +5,018.0% | +8.9% | -72.2% | +5,063.1% | -99.2% | |
| – | – | – | – | – | – | – | – | – | |
| – | +22.0% | -97.9% | +6,334.7% | – | – | – | – | – | |
| – | +0.0% | +0.0% | -47.9% | -106.1% | +156.7% | +200.0% | – | -100.0% | |
| – | +22.0% | -76.3% | +507.8% | -98.8% | -134.3% | +614.2% | – | -97.5% | |
| – | +3.2% | -208.0% | – | -174.6% | – | +167.7% | -226.9% | – | |
| – | – | – | – | – | – | +197.1% | -84.4% | +980.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.